Výsledky vyhledávání - "Recombinant factor VIII N8"

Once-weekly prophylaxis with glycoPEGylated recombinant factor VIII (N8-GP) in severe haemophilia A: Safety and efficacy results from pathfinder 2 (randomized phase III trial)

Autor: Pål Andre Holme, Elena Santagostino, Steven R. Lentz, Claude Negrier, Andrea Landorph, Mudi Misgav, Canan Albayrak, Allison P. Wheeler, Miguel A. Escobar, Robert Klamroth, Nicola Curry, Susan Kearney, Sidsel Marie Tønder, Midori Shima

Publikováno v: Haemophilia

Curry, Nicola/0000-0002-3849-0688; Escobar, Miguel/0000-0002-2944-0240 WOS: 000470929100022 PubMed: 30817066 Introduction Turoctocog alfa pegol (N8-GP) is a site-specific, 40 kDa glycoPEGylated recombinant factor VIII (FVIII) product with an extended

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5662f7793ce8038f413ccd71e57da22a
https://hdl.handle.net/20.500.12712/10847

Zobrazit plný text záznamu

Measuring FVIII activity of glycopegylated recombinant factor VIII, N8-GP, with commercially available one-stage clotting and chromogenic assay kits: a two-centre study

Autor: Andreas Hillarp, Steve Kitchen, Peter Persson, Annette E. Bowyer, Mirella Ezban

Publikováno v: Haemophilia : the official journal of the World Federation of Hemophilia. 23(3)

Introduction: Factor VIII activity (FVIII:C) assays of samples containing glycoPEGylated recombinant FVIII such as turoctocog alfa pegol (N8-GP) can be associated with differences in FVIII recovery in vitro between various one-stage activated partial

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb3919c50dbfd44c5d5f60750d8ef484
https://pubmed.ncbi.nlm.nih.gov/28198071

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání